Shares of Phreesia, Inc. (NYSE:PHR – Get Free Report) have been assigned an average rating of “Hold” from the nineteen brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and nine have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $16.6471.
PHR has been the topic of a number of recent analyst reports. Weiss Ratings upgraded Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, July 20th. Truist Financial boosted their target price on shares of Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a research note on Thursday, May 28th. Stephens cut their price target on shares of Phreesia from $32.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, March 31st. Wall Street Zen raised shares of Phreesia from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $16.00 price objective (down from $24.00) on shares of Phreesia in a report on Tuesday, March 31st.
View Our Latest Analysis on Phreesia
Institutional Trading of Phreesia
Phreesia Stock Performance
Phreesia stock opened at $10.22 on Monday. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market capitalization of $631.51 million, a P/E ratio of 68.11 and a beta of 0.87. Phreesia has a 1-year low of $7.77 and a 1-year high of $32.76. The company’s 50-day moving average is $9.86 and its 200 day moving average is $11.10.
Phreesia (NYSE:PHR – Get Free Report) last announced its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The business had revenue of $130.94 million during the quarter, compared to analyst estimates of $130.08 million. During the same quarter in the previous year, the business earned ($0.07) earnings per share. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. Research analysts forecast that Phreesia will post 0.39 EPS for the current year.
Phreesia Company Profile
Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
Recommended Stories
- Five stocks we like better than Phreesia
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
